Lessons learned from rindopepimut treatment in patients with EGFRvIII-expressing glioblastoma

Transl Cancer Res. 2018 Apr;7(Suppl 4):S510-S513.

David C Binder¹, Erik Ladomersky², Alicia Lenzen², Lijie Zhai², Kristen L Lauing², Sebastian D Otto-Meyer³, Rimas V Lukas^{4

5

6}, Derek A Wainwright^{2

3

5

6

7}

¹ Department of Radiation Oncology, University of Colorado School of Medicine, Aurora, CO, USA.
² Department of Neurological Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
³ Department of Medicine-Hematology/Oncology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
⁴ Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
⁵ Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA.
⁶ Lou and Jean Malnati Brain Tumor Institute, Northwestern University, Chicago, IL, USA.
⁷ Department of Microbiology-Immunology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.

No abstract available

Grants and funding